PHVS

PHARVARIS NV

1 day chart

About PHVS

Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).

Buy US stocks in Australia starting with PHVS. Open an account and start investing today!

Market Capitalisation

$757.89M

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$18.91

Low today

$18.00

Open price

$0.00

52-week high

$26.86

52-week low

$1.77

PHVS FAQs

Can I buy PHVS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy PHVS shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of PHARVARIS NV?

One share of PHARVARIS NV is valued at $19.86.

What is the ticker symbol for PHARVARIS NV?

The ticker symbol for PHARVARIS NV is PHVS.

How do I buy PHVS shares in Australia?

To buy PHVS stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in PHVS

What is the 52-week high for PHARVARIS NV stock?

The PHARVARIS NV 52-week high stock price is $26.86.

What is the 52-week low for PHARVARIS NV stock?

The PHARVARIS NV 52-week low stock price is $1.77.

What is the market capitalisation of PHARVARIS NV PHVS?

As of 04/10/2023 PHARVARIS NV has a market cap of $758M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.